Fundraising Fox
/Companies
Sign in

XiltriX North America

San Diego, US · Founded 2018 · Delaware LLC

Find your way into XiltriX North America

869 people in our graph share verified history with the XiltriX North America team — schools, employers, funds. One of them is your warm intro.

Bradley Sloanunlockedknows Moises Eilemberg · together at Bear, Stearns & Co. Inc. (overlapped)
×7knows the team · via Bear, Stearns & Co. Inc.
×3knows the team · via YPO
knows the team · via ClearLight Partners LLC
Biotech

Founders & leadership

ME
Moises EilembergCEOMoises Eilemberg is an executive officer and director at XiltriX North America, a company that provides real-time laboratory and environmental monitoring systems for life science organizations, drawing on three decades of experience in life science asset management and monitoring technology.

Board

DL
Doron LurieBoard director
HH
Hendrik HanselaarBoard director
EV
Erik van StekBoard director
MO
Michael O'ConnellBoard director
NP
Nathaniel PaigeBoard director

Reported raises · per SEC filings

Form D private placements

$22.6M disclosed across 7 rounds · 2019–2026

▶$3MraisedAug 2026 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Moises EilembergExecutive Officer, Director
  • Erik van StekDirector
  • Hendrik HanselaarDirector
  • Michael O'ConnellDirector
  • Nathaniel PaigeDirector
  • Doron LurieDirector
Offering amount
$3M
Amount sold
$3M
First sale
Aug 2026
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedDec 2024 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hendrik HanselaarDirector
  • Erik van StekDirector
  • Michael O'ConnellDirector
  • Nathaniel PaigeDirector
  • Moises EilembergExecutive Officer, Director
Offering amount
$2.1M
Amount sold
$2.1M
First sale
Nov 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedFeb 2024 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hendrik HanselaarDirector
  • Moises EilembergExecutive Officer, Director
  • Nathaniel PaigeDirector
  • Michael O'ConnellDirector
  • Erik van StekDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Feb 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedFeb 2023 · 15 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Moises EilembergExecutive Officer, Director
  • Erik van StekDirector
  • Michael O'ConnellDirector
  • Hendrik HanselaarDirector
Offering amount
$3.5M
Amount sold
$2.8M
First sale
Jan 2023
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedNov 2021 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hendrik HanselaarDirector
  • Erik van StekDirector
  • Michael O'ConnellDirector
  • Moises EilembergExecutive Officer, Director
Offering amount
$3.8M
Amount sold
$3.8M
First sale
Nov 2021
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.3MraisedSep 2020 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Moises EilembergExecutive Officer, Director
  • Hendrik HanselaarDirector
  • Michael O'ConnellDirector
  • Erik van StekDirector
Offering amount
$4.3M
Amount sold
$4.3M
First sale
Sep 2020
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedMay 2019 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Moises EilembergExecutive Officer, Director
  • Erik van StekDirector
  • Hendrik HanselaarDirector
Offering amount
$4.2M
Amount sold
$4.2M
Minimum investment
$25K
Proceeds to insiders
$25K
First sale
May 2019
Incorporated
Limited Liability Company, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

San Diego California based XiltriX North America is raising $4,275,000.00 in New Equity Investment. - intelligence360intelligence360.news · Oct 2020

Frequently asked questions

How much funding has XiltriX North America raised?
XiltriX North America has disclosed $22.6M raised across 7 rounds.
Where is XiltriX North America headquartered?
XiltriX North America is headquartered in San Diego, US.